Skip to content

Sanara MedTech Inc. SMTI Discontinued operations (in dollars per share)

Discontinued operations (in dollars per share) at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$0.98-288%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s discontinued operations (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s discontinued operations (in dollars per share)?
Sanara MedTech Inc. (SMTI) reported discontinued operations (in dollars per share) of $0.01 in Q1 2026.
How has Sanara MedTech Inc.'s discontinued operations (in dollars per share) changed year-over-year?
Sanara MedTech Inc.'s discontinued operations (in dollars per share) increased by 102.9% year-over-year, from -$0.34 to $0.01.
What does discontinued operations (in dollars per share) mean?
This metric represents the per-share net earnings or losses attributable to business components that have been disposed of or are held for sale. It isolates the financial performance of legacy operations from the company's ongoing core business activities. Analyzing this helps investors evaluate the impact of divestitures on the company's overall profitability and future growth trajectory.